HLA-C and Miyoshi myopathy: Also, the CTL vaccine was prepared from multiple HLA-A2+ normal donors and effective against MM cells from HLA-A2+ patients, and thus could be used with less MHC restriction, although HLA-A2 negative MM patients cannot be covered.